Christadoss, P. Et Al. 2004. Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition. 20th International Complement Workshop , (Hawaii, United States Of America), 221.

Christadoss, P., TÜZÜN, E., Saini, S., & Yang, H., (2004). Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition . 20th International Complement Workshop (pp.221). Hawaii, United States Of America

Christadoss, P Et Al. "Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition," 20th International Complement Workshop, Hawaii, United States Of America, 2004

Christadoss, P Et Al. "Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition." 20th International Complement Workshop , Hawaii, United States Of America, pp.221, 2004

Christadoss, P. Et Al. (2004) . "Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition." 20th International Complement Workshop , Hawaii, United States Of America, p.221.

@conferencepaper{conferencepaper, author={P Christadoss Et Al. }, title={Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition}, congress name={20th International Complement Workshop}, city={Hawaii}, country={United States Of America}, year={2004}, pages={221} }